What Business Model Makes Space Medicine Commercially Viable?
A space medicine company is not simply a clinic with an unusual patient population. It sits where aerospace operations, clinical medicine, human performance, research compliance, biomedical engineering, data analysis, and mission risk management overlap. The Aerospace Medical Association describes the field as clinical care, research, and operational support for the health, safety, and performance of people in air and space vehicles. That broad scope creates several possible businesses, but it also makes an unfocused startup expensive.
The most financeable entry point is usually a services-first model: medical operations consulting, crew health protocol design, preflight screening coordination, medical data systems, countermeasure testing, research program management, or human-factors support. These services can produce contract revenue before the company owns a laboratory, develops a regulated device, or buys access to a flight. A founder can then add higher-value research integration, proprietary software, or hardware once customers and technical evidence exist.
Medical operations
Crew screening
Human research
Biomedical devices
Remote monitoring
Mission data
$125K-$350K
Advisory-first venture
A planning range for a founder-led practice using contracted clinicians, partner facilities, and limited proprietary technology.
$625K-$2.1M
Research and operations company
A planning range for a team that manages studies, handles sensitive data, coordinates laboratories, and carries meaningful working capital.
$1.5M-$5M+
Product or platform company
A planning range when the venture develops regulated hardware, custom software, flight-qualified systems, or its own clinical facility.
The core decision
Choose the first revenue unit before choosing the first laboratory. A signed monthly medical-operations retainer is easier to finance than a device that may require years of validation and uncertain flight access.
Potential customers include launch and reentry operators, private astronaut mission providers, commercial space stations, life-science companies, medical-device developers, defense contractors, insurers, universities, government agencies, and high-net-worth participants. Each buyer has a different procurement cycle. A venture selling to federal programs may wait months for an award; a venture supporting a commercial operator may move faster but face customer concentration. The business plan should therefore separate revenue by customer type, contract structure, and probability of close rather than treating every proposal as sales.
How Much Capital Does a Space Medicine Venture Need?
Direct industry averages are scarce because space medicine companies are usually embedded inside aerospace contractors, research institutions, medical groups, or technology startups. The startup budget should therefore be built from the operating model. A services company needs credentials, insurance, secure systems, proposal capacity, and enough payroll runway to survive long sales cycles. A research company adds protocol development, institutional review board coordination, biospecimen handling, laboratory vendors, data management, and study-specific reserves. A product company adds engineering, testing, quality systems, regulatory strategy, and prototype iterations.
Talent is the largest early cost. U.S. Bureau of Labor Statistics data place May 2024 median pay at $106,950 for bioengineers and biomedical engineers and $100,590 for medical scientists, before payroll taxes, benefits, recruiting, and specialist premiums. Those national medians are useful planning anchors, not quotes for aerospace-qualified personnel; experienced physicians, principal investigators, regulatory leaders, and mission-operations specialists may cost materially more. See the BLS biomedical engineering profile when constructing salary assumptions.
| Startup use of funds |
Planning range |
What the money covers |
| Formation, contracts, regulatory and clinical counsel |
$30,000-$100,000 |
Entity setup, customer terms, informed-consent review, intellectual property, export-control screening, and study agreements. |
| Clinical and scientific team ramp |
$150,000-$450,000 |
Founder salary, part-time medical director, research lead, engineer, project manager, benefits, recruiting, and credentialing. |
| Facility, lab access, and equipment |
$75,000-$300,000 |
Lease deposits, examination space, monitoring equipment, cold-chain tools, sample storage, calibration, and partner-facility fees. |
| Data, cybersecurity, and quality systems |
$50,000-$180,000 |
Electronic data capture, secure cloud architecture, validation, audit trails, privacy controls, document management, and backups. |
| Insurance, compliance, and professional services |
$30,000-$120,000 |
Professional liability, general liability, cyber coverage, directors and officers coverage, accounting, and quality consulting. |
| Business development and proposal pipeline |
$40,000-$150,000 |
Travel, industry meetings, demonstrations, technical proposals, capture support, and partner due diligence. |
| Six to twelve months of working capital |
$250,000-$800,000 |
Payroll and vendor payments while proposals, milestones, invoices, and customer acceptance move through long cycles. |
| Total planning range |
$625,000-$2.1M |
A research-and-operations model without owning launch infrastructure or a major flight-qualified hardware program. |
What this estimate hides is timing. A $1.2M budget does not mean spending $100,000 every month. Legal work, insurance, and systems arrive early; research vendors and travel may spike around study milestones; payroll becomes the steady burn. The financial model should schedule each use of funds by month and hold a contingency of roughly 10%-20% for protocol changes, security requirements, subcontractor overruns, or delayed customer acceptance. That contingency is an assumption, but omitting it is a common cause of emergency fundraising.
The Operating Cost Structure Is Talent-Heavy and Contract-Driven
Space medicine operating economics resemble a specialized clinical research organization and engineering consultancy more than a conventional physician office. Payroll is high, utilization is uneven, and some direct costs appear only when a study or mission reaches a milestone. The company must distinguish fixed salary from billable project labor, because a scientist can be fully employed but only partly billable while writing proposals, maintaining protocols, publishing, training, or waiting for customer data.
Physician compensation can materially change the model. The BLS physician and surgeon profile shows that physician pay varies substantially by specialty and setting. A startup rarely needs every specialty on payroll. A better early design is one accountable medical director, a compact core research and program team, and contracted specialists in cardiology, behavioral health, radiology, ophthalmology, emergency medicine, rehabilitation, or radiation health as protocols require.
| Monthly operating expense |
Planning range |
Cost behavior |
| Core payroll |
$65,000-$180,000 |
Mostly fixed; increases in steps when a medical director, principal investigator, engineer, data lead, or project manager is hired. |
| Benefits and payroll taxes |
$15,000-$45,000 |
Fixed relative to headcount; model as a percentage of salary plus recruiting and training cost. |
| Facility and laboratory access |
$8,000-$30,000 |
Partly fixed; can remain variable through university, hospital, imaging, centrifuge, or sample-processing partnerships. |
| Insurance, legal, quality, and compliance |
$8,000-$30,000 |
Baseline fixed cost with spikes for new studies, contracts, claims history, audits, and regulatory submissions. |
| Software, data, and cybersecurity |
$5,000-$20,000 |
Fixed subscriptions plus usage fees for storage, analytics, device connectivity, validation, and external security reviews. |
| Business development and travel |
$10,000-$35,000 |
Discretionary but necessary; should be tied to qualified pipeline, proposal value, and customer acquisition payback. |
| Subcontractors, IRB, labs, and participant logistics |
$10,000-$60,000 |
Variable or milestone-driven; pass through where contracts permit and protect with change-order language. |
| General and administrative |
$5,000-$20,000 |
Accounting, recruiting, office operations, communications, insurance administration, and non-project supplies. |
| Total monthly operating range |
$126,000-$420,000 |
The lower end fits a partner-heavy team; the upper end fits a staffed research company with several active programs. |
Illustrative base-case monthly cost mix
Payroll and associated benefits can absorb about two-thirds of operating spend before project-specific flight, laboratory, or participant costs.
Core payroll
55%
Benefits and taxes
13%
Subcontractors and labs
12%
Facility and systems
10%
Sales, legal, and G&A
10%
The practical one-liner is simple: keep rare expertise close, but keep idle capacity off payroll. Management span also matters. One strong program director may oversee three to five complex workstreams only when each project has a capable lead and disciplined documentation. Beyond that point, coordination failures create rework, overtime, and missed milestones that are more expensive than adding a manager.
How Does a Space Medicine Company Earn Revenue?
Revenue should be built from deliverables rather than vague consulting hours. NASA’s own medical and pharmacology capabilities include astronaut selection and certification, mission operations, protocol and system development, and high-level space medicine expertise. A private company can address adjacent commercial needs, but it must define exactly what the customer receives: a medical standard, screening workflow, study protocol, validated dataset, flight rule, monitoring system, integration package, or completed research milestone.
The ranges below are planning assumptions for U.S. contract modeling, not published industry tariffs. Direct price transparency is limited, and the same task can differ sharply by mission duration, participant risk, data rights, export controls, regulatory scope, hardware maturity, indemnification, and whether the customer supplies facilities or flight access.
| Revenue unit |
Illustrative price |
Primary direct costs |
Planning contribution margin |
| Medical operations retainer |
$15,000-$40,000 per month |
Medical director time, protocol maintenance, meetings, incident review, and on-call coverage. |
45%-65% |
| Participant screening program |
$5,000-$15,000 per participant |
Specialist examinations, imaging, laboratories, records review, coordination, and medical reporting. |
25%-45% |
| Protocol and IRB-ready study package |
$40,000-$150,000 per project |
Principal investigator, biostatistics, clinical writing, consent documents, data plan, and revision rounds. |
40%-60% |
| Clinical or human-performance study operations |
$150,000-$750,000 per study |
Participant management, sites, laboratories, devices, travel, data management, monitoring, and reporting. |
20%-40% |
| Device validation and mission integration |
$250,000-$1.5M per program |
Engineering, testing, safety documentation, software, quality records, prototype builds, and integration support. |
25%-50% |
| Monitoring or analytics platform |
$50,000-$250,000 annual enterprise license |
Cloud infrastructure, security, customer support, validation, device interfaces, and ongoing product development. |
65%-85% after implementation |
Build a mix that smooths mission timing
A healthy model combines recurring retainers with milestone projects. Retainers cover baseline payroll; study and integration contracts create growth; software or data products improve margin after the installed base develops. A company funded only by flight-linked projects may show a strong backlog yet experience months of low billings when launch schedules move. A company funded only by hourly consulting can generate cash sooner but may never build defensible intellectual property.
Price fixed-fee projects from a work breakdown structure, not optimism. Include protocol revisions, customer review cycles, data cleaning, safety reporting, travel days, hardware failures, and closeout. Use milestone billing such as 20% at kickoff, 25% after protocol acceptance, 25% after data collection, 20% after analysis, and 10% after final acceptance. This reduces the amount of payroll the company must finance for the customer.
What Does Break-Even Look Like Before Flight Volume Scales?
Space medicine businesses should calculate break-even using contribution margin, not gross invoice value. A $1M flight research contract may carry pass-through launch, laboratory, travel, or hardware expenses that contribute little toward fixed cost. The correct question is how much of each revenue dollar remains after costs that rise directly with the work.
Flight scarcity is a structural constraint. NASA states that it anticipates supporting up to two short-duration private astronaut missions to the International Space Station per year, subject to spacecraft traffic and station constraints. That does not cap the entire commercial market, but it shows why a business should not assume smooth monthly access to orbital participants. Review NASA’s commercial space FAQ when building flight-dependent volume assumptions.
$167K/month
Lean advisory break-even
Assumes $100,000 fixed monthly cost and 60% contribution margin. This can be reached with four to seven substantial retainers or a mixed retainer-project book.
$423K/month
Research-operations break-even
Assumes $220,000 fixed monthly cost and 52% contribution margin. Backlog must be scheduled into monthly billings, not merely signed.
$750K/month
Product-heavy break-even
Assumes $300,000 fixed monthly cost and 40% contribution margin during development, before software scale or mature manufacturing economics.
The sensitivity that matters most
A five-point margin miss is expensive. At $5M of annual revenue, dropping from a 52% to a 47% contribution margin removes $250,000 of annual contribution. A three-month delay in a $600,000 study milestone can create a temporary cash hole even when the annual income statement still shows profit. The model should therefore include separate sensitivities for award timing, flight timing, billable utilization, subcontractor cost, milestone acceptance, and customer concentration.
Planning mistake to avoid
Do not count the full value of a multi-year award as current-year revenue. Recognize revenue by deliverable or performance obligation, model invoice dates separately, and delay cash collection by the contract’s payment terms.
Clinical Governance, Human Research, and Flight Scarcity Shape Cash Flow
Compliance is not an administrative afterthought; it changes project scope, staffing, insurance, and cash timing. Federally supported human-subject research may fall under the Common Rule, which sets requirements for institutional review boards, informed consent, and assurances of compliance. The HHS Office for Human Research Protections is the appropriate starting point for determining how those rules apply. A customer may also require its own ethics, privacy, security, or medical-governance standards even when a specific federal rule does not apply.
Device studies create another branch. The FDA explains that an investigational device exemption can permit a device to be used in a clinical study to collect safety and effectiveness data, and significant-risk device studies generally require FDA and IRB approval before starting. Review the FDA IDE overview before estimating regulatory labor or study start dates. Regulatory classification should be handled by qualified counsel and specialists, not guessed from a business plan.
| Risk |
Typical financial effect |
Model treatment |
Control |
| Launch or mission delay |
Milestone revenue shifts while payroll and readiness costs continue. |
Run 3-, 6-, and 12-month delay cases; separate non-flight deliverables from flight execution. |
Use mobilization fees, readiness retainers, rescheduling terms, and diversified ground-based work. |
| IRB or protocol revision |
Additional investigator, biostatistics, consent, and document-control hours. |
Carry a 10%-20% study design contingency and cap included revision rounds. |
Use pre-submission review, clear decision rights, and written change orders. |
| Fixed-price project overrun |
Direct labor rises without additional revenue, compressing contribution margin. |
Track estimated cost to complete weekly and reforecast margin at each milestone. |
Define assumptions, exclusions, acceptance criteria, and customer dependencies. |
| Key-person dependence |
Proposal loss, project pause, or customer concern if one physician or scientist becomes unavailable. |
Add succession, cross-training, and specialist backup cost to overhead. |
Document clinical decisions and maintain approved alternates. |
| Medical-data or cyber event |
Incident response, legal review, customer remediation, higher premiums, and reputational damage. |
Budget external testing, cyber insurance, backups, and an incident reserve. |
Minimize data, segment systems, control access, log activity, and test recovery. |
| Customer concentration |
One delayed renewal can remove a large portion of annual revenue. |
Stress-test loss of the largest customer and cap hiring against uncontracted renewals. |
Build multiple buyer segments and reusable capabilities. |
6-12 months
A prudent working-capital target for an early research-oriented venture, especially when customer awards, ethics review, mission scheduling, and milestone acceptance can move independently. This is a planning assumption, not a universal benchmark.
The cash cycle should be modeled as four different dates: work performed, milestone accepted, invoice issued, and cash received. Profit appears when revenue is recognized; cash arrives only after the last step. Use deposits and milestone payments to limit work in progress, and negotiate pass-through vendor costs so the company is not financing laboratories, travel, or participant logistics for months.
Which KPIs Show Whether the Model Is Working?
Space medicine performance cannot be judged by revenue alone. A growing company can still destroy cash through low utilization, weak project margins, slow collections, or a pipeline dominated by one uncertain flight. NASA’s Human Research Program organizes risk around radiation, isolation and confinement, distance from Earth, altered gravity, and closed or hostile environments. Those hazards explain why the work is multidisciplinary and why quality failures can be costly. The NASA hazard framework is also a useful way to map which capabilities and research programs the company actually supports.
The KPI ranges below are management assumptions for a contract-based space medicine venture. Exact targets should be calibrated to contract type, accounting policy, team seniority, federal versus commercial customers, and whether pass-through costs are included in reported revenue.
| KPI |
Formula |
Planning interpretation |
Financial-model connection |
| Backlog coverage |
Signed remaining contract value ÷ next 12 months of fixed cost |
Above 1.0x improves hiring confidence; below 0.5x means the team depends heavily on unawarded pipeline. |
Controls hiring dates, financing need, and downside burn. |
| Billable utilization |
Billable hours ÷ available professional hours |
A 55%-70% range may be workable for senior staff who also sell, govern quality, and develop methods; persistent levels below 45% need action. |
Drives labor absorption and project contribution margin. |
| Project contribution margin |
Revenue less direct project cost ÷ project revenue |
Target more than 40% for advisory and protocol work; complex study operations may be lower. Below 25% leaves little room for overhead. |
Feeds blended margin and break-even revenue. |
| Revenue per average FTE |
Annual revenue ÷ average full-time-equivalent headcount |
A mature services-led target of roughly $300,000-$500,000 per FTE can support specialist pay; compare on net revenue if pass-through costs are large. |
Links capacity, hiring, pricing, and revenue scale. |
| Days sales outstanding |
Accounts receivable ÷ annual credit revenue × 365 |
Under 60 days is healthier; more than 90 days can require a working-capital line even when projects are profitable. |
Determines collection lag and cash minimum. |
| Qualified proposal win rate |
Won qualified proposals ÷ submitted qualified proposals |
A 25%-40% planning range may be reasonable after strict qualification; a high rate can still be bad if pricing is too low. |
Converts pipeline into probability-weighted bookings. |
| Customer acquisition payback |
Sales and capture cost ÷ monthly contribution from new customers |
Aim to recover enterprise acquisition cost within 12-18 months unless the contract has strategic follow-on value. |
Sets sustainable business-development spend. |
| Top-customer concentration |
Largest customer revenue ÷ total revenue |
Above 35% deserves a specific loss scenario; early companies may exceed it, but should not ignore the dependency. |
Shapes downside revenue, reserves, and valuation risk. |
| Milestone on-time rate |
Milestones accepted on time ÷ milestones due |
Below 90% indicates scope, staffing, customer-dependency, or quality issues that may delay cash. |
Moves invoice timing and cost-to-complete forecasts. |
Use one operating dashboard, not separate scientific and financial stories
Every study or customer program should show contract value, recognized revenue, billed amount, cash collected, cost incurred, estimated cost to complete, contribution margin, next milestone, clinical owner, and delivery risk on the same page.
The practical one-liner: backlog pays no bills until work becomes an accepted invoice. Review the dashboard weekly for cash and delivery, monthly for margin and utilization, and quarterly for customer concentration, pricing, and headcount capacity.
How Much Can the Owner Realistically Earn?
Owner income is not revenue, gross profit, or even EBITDA. A physician-founder may receive a market salary for clinical or executive work and still take no distribution because the company needs cash for debt service, taxes, regulatory work, replacement equipment, proposal costs, and delayed collections. Conversely, a profitable advisory practice may distribute cash sooner because it carries less inventory and capital equipment.
The U.S. labor market provides a useful opportunity-cost check. Medical scientists had a May 2024 median wage of $100,590, while natural sciences managers had a median wage of $161,180. Those figures do not set founder pay, but they show why underpaying critical scientific leadership can create turnover and why a founder’s salary should be separated from the return on invested capital. The BLS medical scientist profile is a reasonable salary-planning reference.
| Annual scenario |
Conservative |
Base |
Upside |
| Revenue |
$2.4M |
$5.4M |
$8.5M |
| Contribution margin |
42% |
52% |
58% |
| Contribution dollars |
$1.01M |
$2.81M |
$4.93M |
| Fixed operating cost, including founder salary |
$1.15M |
$1.90M |
$2.70M |
| EBITDA |
-$142,000 |
$908,000 |
$2.23M |
| Debt service |
$120,000 |
$180,000 |
$250,000 |
| Tax reserve |
$0 |
$180,000 |
$450,000 |
| Maintenance capex and working-capital reserve |
$75,000 |
$230,000 |
$450,000 |
| Potential distributable cash |
$0 |
About $318,000 |
About $1.08M |
In the base case, the founder might already receive a $180,000-$250,000 salary included in fixed cost, then receive some or all of the $318,000 distributable cash depending on ownership, board policy, and reinvestment. The owner should not automatically withdraw the full amount. A company with one dominant contract or a major study starting next quarter may need to retain most of it. Existing businesses should compare normalized owner compensation with market pay and then value the residual profit separately.
Funding Strategy and a Financially Sequenced Launch
The capital stack should match technical and commercial risk. Founder capital and specialized angels can fund formation, customer discovery, and the first team. Customer-funded development and milestone deposits are the best financing when available because they validate demand. Non-dilutive programs can support technology maturation. NASA’s SBIR/STTR program serves U.S. small businesses developing relevant technologies, and 2026 program materials describe competitive Phase I and Phase II opportunities. Start with the NASA 2026 SBIR/STTR information hub and always model grants as uncertain until awarded.
Debt is more appropriate after the company has contracts, collateral, or reliable recurring revenue. SBA 7(a) proceeds can be used for working capital, equipment, facilities, and other eligible business purposes, and most 7(a) loans have a maximum amount of $5M. Eligibility and terms depend on the borrower and lender; see the SBA 7(a) program. Borrowing before revenue visibility can turn a technical delay into a solvency problem because principal and interest continue even when a flight or study moves.
Months 0-3
Choose one wedge and design governance
Select the first buyer, deliverable, and revenue unit. Establish clinical responsibility, legal structure, data boundaries, insurance strategy, and a 24-month cash model. Planning spend: roughly $75,000-$200,000.
Months 3-6
Build the minimum credible operating system
Create procedures, templates, secure data workflows, quality records, subcontractor agreements, pricing, and proposal materials. Keep facilities flexible. Cumulative spend: roughly $175,000-$450,000.
Months 6-12
Close paid pilots and protect working capital
Sell ground analog studies, protocol work, screening coordination, or operator support that does not depend on a launch. Negotiate deposits and monthly billing. Cumulative funding need: roughly $400,000-$1.0M.
Months 12-24
Scale only against contracted demand
Add full-time specialists, deeper regulatory capability, product development, or dedicated space only when backlog covers the step-up. Additional capital may range from $500,000 to $2M depending on hardware and study scope.
Step 1
Validate demand
Secure paid discovery, a pilot, letter of intent, or subcontract before building a large permanent team.
Step 2
Price the scope
Estimate labor, specialists, facilities, data, contingencies, and acceptance cycles by milestone.
Step 3
Fund the gap
Match equity, non-dilutive awards, deposits, and debt to the period before customer cash arrives.
Step 4
Release capital in gates
Hire and buy equipment only after technical, regulatory, and commercial milestones are met.
A lender-ready package needs more than an exciting market story. It should include signed contracts or realistic pipeline evidence, resumes and licenses, a use-of-funds schedule, monthly cash flow, downside cases, debt-service coverage, insurance, customer concentration, regulatory dependencies, and a clear explanation of who pays if a mission moves. Founders often use a financial model, business plan, and pitch deck together so the operating assumptions, funding ask, and investor narrative reconcile.
What Payback Period Is Realistic?
Payback should be calculated from cash available to repay the initial investment, not EBITDA alone. A venture may report positive EBITDA while using cash to build receivables, fund a study, replace devices, or meet loan payments. NASA’s Human Research Program offers collaboration and funding pathways across research and technology areas, but awards and partnerships are competitive and should not be assumed. The HRP collaboration page is a useful source for understanding how external organizations may engage.
8-12+ years
Conservative case
A $1.2M initial investment with only $100,000-$150,000 of annual cash available after a slow ramp. Payback may never occur if customer concentration or project losses persist.
4-5 years
Base case from formation
A $1.2M investment, an 18-month ramp, and about $400,000 of annual cash available once stabilized. Stabilized payback alone looks like three years, but the ramp adds time.
2.5-3 years
Upside case
A faster contract ramp, 55%+ blended contribution margin, strong deposits, and roughly $800,000 of annual cash available after reserves.
Payback stretches when flight timing shifts, fixed-price studies overrun, receivables grow, a second regulatory pathway appears, or the company hires ahead of backlog. It shortens when customers fund development, retainers cover fixed payroll, reusable protocols reduce delivery time, software revenue grows, and milestone billing keeps work in progress low. A ten-point change in contribution margin can move payback by years, so margin sensitivity deserves more attention than a single headline market-growth rate.
Investment logic
A credible base case should repay invested capital without assuming one unawarded government program, one specific launch, or a future acquisition. Treat those outcomes as upside, not the plan.
Connecting the Financial Model from Contracts to Cash
The financial model is the operating map. It should connect commercial assumptions to staffing, project delivery, cash, and owner returns in a way that can be updated when a launch, study, or award changes. FAA human-spaceflight rules illustrate why operational assumptions must also reflect regulatory roles: 14 CFR Part 460 includes crew qualification, training, medical, environmental control, and informed-consent requirements for relevant operators and participants. Review the current 14 CFR Part 460 and obtain specialist advice when the business supports regulated flight operations.
Startup investment
Contracted backlog
Milestones and volume
Direct project cost
Fixed operating cost
Cash and owner earnings
Payback and valuation
Build the model in seven connected schedules
-
Startup and funding schedule: formation, systems, equipment, hiring, deposits, contingency, equity, grants, debt, and cash minimum by month.
-
Pipeline and bookings schedule: each opportunity, customer type, contract value, probability, expected award date, period of performance, and renewal assumption.
-
Revenue schedule: retainer months, participant counts, study milestones, licenses, data deliverables, and revenue-recognition timing.
-
Capacity and staffing schedule: available hours, billable utilization, project roles, salary, benefits, contractors, recruiting lead time, and management span.
-
Project-cost and margin schedule: direct labor, labs, participant costs, travel, devices, flight-related costs, contingency, and cost to complete.
-
Cash-flow schedule: invoice timing, deposits, payment terms, accounts receivable, vendor timing, debt service, taxes, capital spending, and reserves.
-
Return schedule: EBITDA, operating cash flow, owner salary, distributable cash, cumulative investor cash, payback, and downside runway.
Run at least three scenarios. The conservative case should delay awards and flights, reduce win rate and utilization, compress margin, and extend collections. The base case should use contracted evidence and achievable staffing. The upside case can add new customers, reusable technology, or higher-margin software, but should still respect delivery capacity. Update the model monthly from actual timesheets, project forecasts, invoice status, and cash balances.
The best space medicine venture is not necessarily the one with the most ambitious science. It is the one that turns scarce expertise into clearly priced deliverables, protects clinical quality, bills before cash pressure becomes acute, and expands only when backlog supports the next layer of talent and technology. That discipline is what converts a technically compelling idea into a durable U.S. business.
